| Hans Groth |
Described as "Senior Director, Healthcare Policy & Market Access, Oncology Business Unit, Pfizer Europe" on the 2011 Bilderberg guest list.
Hans Groth was described as "Senior Director, Healthcare Policy & Market Access, Oncology Business Unit, Pfizer Europe" on the 2011 Bilderberg guest list.
"MD; MBA. Until 2012, worked with Pfizer. Chairman of the Board, World Demographic & Ageing Forum (WDA Forum). President, Academia Engelberg Foundation, a platform for dialogue between science and society. Member of the Board of Directors, RehaClinic Bad Zurzach, the largest Switzerland-based chain of rehabilitation clinics. Since 2009, permanent guest lecturer at the University of St Gallen (HSG), Switzerland. Experience in over 30 healthcare systems including Western Europe, Eastern Europe, the US and Canada. Past 12 years studying the interaction between global demographic change, economic development, wealth and societal stability. Focus of research built upon theories of economic development and productivity, and employing the value of health, education and progress in societal governance as sustainable tools to unlock new ways to tackle the imminent challenges of demographic change."
Event Participated in
|Bilderberg/2011||9 June 2011||12 June 2011||Switzerland|
|This is a page stub. Please add to it.|